Australia markets closed

Virios Therapeutics, Inc. (VIRI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.5300+0.0400 (+1.15%)
At close: 04:00PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
0
Operating expenses
Research development
10,796
10,796
194.013
836.175
854.109
Selling general and administrative
4,845
4,845
9,811
1,342
1,107
Total operating expenses
15,641
15,641
10,005
2,178
1,961
Operating income or loss
-15,641
-15,641
-10,005
-2,178
-1,961
Interest expense
-
-
384.222
295.128
152.103
Total other income/expenses net
-325
-325
43.221
-
0.006
Income before tax
-15,960
-15,960
-10,346
-2,474
-2,114
Income tax expense
0
0
0
0
0
Income from continuing operations
-15,960
-15,960
-10,346
-2,474
-2,114
Net income
-15,960
-15,960
-10,346
-2,474
-2,114
Net income available to common shareholders
-15,960
-15,960
-10,346
-2,474
-2,114
Basic EPS
-
-
-2.10
-0.51
-0.44
Diluted EPS
-
-
-2.10
-0.51
-0.44
Basic average shares
-
-
4,927
4,832
4,832
Diluted average shares
-
-
4,927
4,832
4,832
EBITDA
-
-15,641
-9,962
-2,178
-1,961